MedTrace Logo

Placebo Effects Investigated by Different Experimental Designs

NCT04317157 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2021-06-15

No results posted yet for this study

Summary

This study aims to investigate the neurophysiological mechanisms of placebo perceived as caffeine during a motor task. Central and peripheral measures (i.e. electroencephalography and electromyography) will be assessed.

Conditions

  • Caffeine
  • Placebo
  • Baseline

Interventions

DIETARY_SUPPLEMENT

Caffeine

Specific dosage of caffeine for each participant (6 mg.kg-1).

OTHER

Placebo

Placebo pill.

Sponsors & Collaborators

  • Newcastle University

    collaborator OTHER

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Flavio O Pires, Phd · School of Arts, Sciences and Humanities - University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2022-07-31
Completion
2022-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04317157 on ClinicalTrials.gov